Neurontin (Gabapentin)

Gabapentin, the active ingredient in Neurontin, is a gabapentinoid presented as an oral tablet for oral use. It is employed to manage certain seizure types and neuropathic pain conditions in adult patients. The medication works by modulating calcium channel activity, which helps reduce abnormal neuronal firing associated with seizures and pain.

GNH USA supplies Neurontin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for global distribution.

Gabapentin is used to treat neurological disorders and neuropathic pain conditions.

- Partial seizures: reduces seizure frequency in adults. - Post‑herpetic neuralgia: alleviates chronic pain following shingles. - Diabetic peripheral neuropathic pain: eases burning and tingling sensations. - Restless legs syndrome: diminishes uncomfortable leg sensations and the urge to move.

Common side effects are generally mild and may resolve with continued therapy.

Common Side Effects: - Dizziness - Somnolence - Peripheral edema - Fatigue - Nausea - Weight gain

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Anaphylactic reactions - Suicidal thoughts or behavior - Respiratory depression, especially with CNS depressants - Angioedema - Severe blood dyscrasias such as agranulocytosis

Before initiating therapy, consider the following safety measures.

- Renal impairment: adjust dose based on creatinine clearance. - Pregnancy: risk unknown; prescribe only if benefit outweighs potential harm. - Elderly patients: monitor for increased CNS sensitivity. - Concomitant CNS depressants: watch for additive sedation. - Avoid abrupt discontinuation: taper gradually to prevent withdrawal symptoms. - Store at ambient temperature: keep in the original pack, protect from moisture.

Gabapentin may interact with several medicines; assess the clinical relevance before co‑administration.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce gabapentin absorption. - Opioids: increased risk of respiratory depression. - CNS depressants (e.g., benzodiazepines, alcohol): enhanced sedation and dizziness.

Moderate Interactions (Monitor Closely): - Diuretics: may raise gabapentin plasma concentrations. - ACE inhibitors: potential for additive hypotensive effect. - Other anticonvulsants (e.g., carbamazepine): may lower gabapentin efficacy.